Maintenance Treatment of Anemia in Pre-dialysis Subjects With Chronic Kidney Disease on Darbepoetin Treatment Versus BAY85-3934
NCT02021409
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
126
Enrollment
INDUSTRY
Sponsor class
Conditions
Anemia
Renal Insufficiency, Chronic
Interventions
DRUG:
BAY85-3934
BIOLOGICAL:
Darbepoetin alfa
Sponsor
Bayer